BAXTER INTERNATIONAL INC. Q3/9M 2025 TL;DR
STRATEGIC & STRUCTURAL CHANGES The strategic transformation is dominated by the Kidney Care business divestiture, which closed January 31, 2025, generating \(\sim\\)3.71B\( in cash proceeds. This segment is now reported as discontinued operations, resulting in a significant \)$(299)M\( loss (including a \)$430M\( goodwill impairment) for the nine months ended September 30, 2025, contrasting with a gain the prior year. Associated assets (\\)5.1B) and liabilities ($1.5B) have been removed from continuing operations balances. The company is managing
...